Pharma stocks surge 10% within 30 days of new FDA chief confirmation

Approval timelines for pipeline drugs will tighten, increasing revenue projections for major pharma players. Investors will reward companies with the highest exposure to expedited approvals.

Implied probability (Yes)

60%